Evidence map›Paper›PMID 22448915›Full record

ArticleMicrobial cell factories2012

De novo sequencing, assembly and analysis of the genome of the laboratory strain Saccharomyces cerevisiae CEN.PK113-7D, a model for modern industrial biotechnology.

Jurgen F Nijkamp, Marcel van den Broek, Erwin Datema, Stefan de Kok, Lizanne Bosman, Marijke A Luttik, Pascale Daran-Lapujade, Wanwipa Vongsangnak, Jens Nielsen, Wilbert H M Heijne and 9 more

Open access · goldAbstract read
In one paragraph

Article in Microbial cell factories, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 152 papers.

0numbers the graph read from it
0cells of the map it votes in
152citing papers in PubMed
10.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

152 citing papers in PubMed, 300 citations in OpenAlex.

  1. Article
  2. Safety and efficacy of a feed additive consisting of riboflavin 80% (vitamin BEFSA journal. European Food Safety Authority · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. The origins of the Guinness stout yeast.Communications biology · 2024
    Article
  20. Article

92 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 6 countries.

Jurgen F NijkampThe Delft Bioinformatics Lab, Department of Intelligent Systems, Delft University of Technology, Mekelweg 4, 2628 CD Delft, The Netherlands.
Marcel van den Broek
Erwin Datema
Stefan de Kok
Lizanne Bosman
Marijke A Luttik
Pascale Daran-Lapujade
Wanwipa Vongsangnak
Jens Nielsen
Wilbert H M Heijne
Paul Klaassen
Chris J Paddon
Darren Platt
Peter Kötter
Roeland C van Ham
Marcel J T Reinders
Jack T Pronk
Dick de Ridder
Jean-Marc Daran
Delft University of Technology · NLAmyris (United States) · USCancer Genomics Centre · NLCentre for BioSystems Genomics · NLChalmers University of Technology · SEDSM (Netherlands) · NLJuliana Kinderziekenhuis · NLGoethe University Frankfurt · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Saccharomyces cerevisiae CEN.PK 113-7D is widely used for metabolic engineering and systems biology research in industry and academia. We sequenced, assembled, annotated and analyzed its genome. Single-nucleotide variations (SNV), insertions/deletions (indels) and differences in genome organization compared to the reference strain S. cerevisiae S288C were analyzed. In addition to a few large deletions and duplications, nearly 3000 indels were identified in the CEN.PK113-7D genome relative to S288C. These differences were overrepresented in genes whose functions are related to transcriptional regulation and chromatin remodelling. Some of these variations were caused by unstable tandem repeats, suggesting an innate evolvability of the corresponding genes. Besides a previously characterized mutation in adenylate cyclase, the CEN.PK113-7D genome sequence revealed a significant enrichment of non-synonymous mutations in genes encoding for components of the cAMP signalling pathway. Some phenotypic characteristics of the CEN.PK113-7D strains were explained by the presence of additional specific metabolic genes relative to S288C. In particular, the presence of the BIO1 and BIO6 genes correlated with a biotin prototrophy of CEN.PK113-7D. Furthermore, the copy number, chromosomal location and sequences of the MAL loci were resolved. The assembled sequence reveals that CEN.PK113-7D has a mosaic genome that combines characteristics of laboratory strains and wild-industrial strains.

Indexed as

Genome, FungalBiotechnologyDNA Copy Number VariationsDNA, FungalGenes, FungalMetabolic EngineeringOpen Reading FramesSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSequence Analysis, DNADNA, FungalSaccharomyces cerevisiae Proteins

Identifiers

PMID22448915
PMCPMC3364882
OpenAlexW2096336948

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.